Smartlegen AS
Score · fiscal year 2025
35of 100
How to read this: the company is ahead of 17 % of companies in the Morning class Medium in the same sector in 2025. What does this mean?
Rank in the Morning class Medium: 146 of 176 · What are Morning company classes?
Place in the whole sector: 1,574 of 1,997 · Helse og omsorg
Profile
Beaver · Builder
Lower profitability, lower solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 12 and solidity 34 out of 100 among companies in the Morning class Medium in the same sector in 2025. Methodology
Against the sector
Smartlegen AS is 17 points below the median for companies in the Morning class Medium in the same sector in 2025.
Median score 52 among 176 companies.
Against companies in the Morning class Medium in the same sector in 2025: operating margin −2.3% (median 3.6%) and equity ratio 27.7% (median 40.8%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 208 MNOK | 92 MNOK |
| Operating margin | −2.3% | 3.6% |
| Profit margin | −2.5% | 4.4% |
| Return on assets | −7.7% | 7.8% |
| Equity ratio | 27.7% | 40.8% |
| Debt-to-equity | 2.60 | 1.35 |
| Current ratio | 0.76 | 1.41 |
| Revenue growth | 1,987.3% | 5.7% |
| Revenue per employee | 0.42 MNOK | 0.93 MNOK |
The median and “ahead of” refer to companies in the Morning class Medium in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 35, Smartlegen AS does better than 17% of companies in the Morning class Medium in the same sector (176 companies) in 2025.
Score 2023–2025
- Smartlegen AS
- Median: companies in the Morning class Medium in the same sector
Smartlegen AS has a score of 35 for 2025, rank 1,574 of 1,997 in the sector.
Strongest: Growth: percentile 100 against peers, revenue growth 1,987.3% against a median of 5.7%.
Weakest: Liquidity: percentile 11 against peers, current ratio 0.76 against a median of 1.41. Profitability: percentile 12 against peers, operating margin −2.3% against a median of 3.6%.
Worth a closer look
- Consider strengthening liquidity: current liabilities are 1.3 times current assets. Based on: current ratio 0.76 (median 1.41).
- The company made a loss before tax. Are these one-off items or a pattern? Based on: profit margin −2.5% (median 4.4%).
- The operating margin is lower than at three in four companies in the sector. Where do costs differ from competitors? Based on: operating margin −2.3% (median 3.6%).
- What lies behind weak profitability, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
Smartlegen AS had an operating margin of −2.3% and an equity ratio of 27.7% in 2025, and ranks 1,574 of 1,997 in Helse og omsorg.
From 2024 to 2025: revenue grew by 1,987% and the equity ratio fell from 78.9% to 27.7%.
This text is generated automatically from the 2025 accounts.
Three simple methods
One method gives a figure: 17 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | not meaningful |
| EV/EBIT | 8.0 | not meaningful |
| P/B | 1.0 | 17 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
Consider strengthening liquidity: current liabilities are 1.3 times current assets.
Based on: Current ratio 0.76 (median 1.41).
- watch
The company made a loss before tax. Are these one-off items or a pattern?
Based on: Profit margin −2.5% (median 4.4%).
- watch
The operating margin is lower than at three in four companies in the sector. Where do costs differ from competitors?
Based on: Operating margin −2.3% (median 3.6%).
- watch
Strong growth with weak liquidity. Is the growth financed, or does it tie up capital the company does not have?
Based on: Revenue growth 1,987.3% (median 5.7%); Current ratio 0.76 (median 1.41).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 1.1% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2026, the sector's weakest year, for this company.
The sector's weakest year was 2026, with a median operating margin of −10.4%. Based on the 6 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 12 | weight 30% |
|---|---|---|
| Solidity | 34 | weight 25% |
| Liquidity | 11 | weight 15% |
| Growth | 100 | weight 15% |
| Consistency | 41 | weight 15% |
Durability: 23 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is Smartlegen AS?
The operating margin was −2.3% in 2025, against a median of 3.6% among companies in the Morning class Medium in the same sector. Return on assets was −7.7%. The company made a loss before tax.
How solid is Smartlegen AS?
The equity ratio was 27.7% in 2025 (median 40.8%). Debt-to-equity was 2.60 (median 1.35).
What is the liquidity of Smartlegen AS like?
The current ratio was 0.76 in 2025 (median 1.41). Current assets did not cover current liabilities.
How does Smartlegen AS compare in Helse og omsorg?
Smartlegen AS ranks 1,574 of 1,997 in Helse og omsorg for 2025. Among companies in the Morning class Medium it is number 146 of 176. Revenue changed by 1,987.3% from the year before.
Group accounts
The company is registered as part of a group, but we have no group accounts for it. Group accounts are filed by the parent company, and open data does not say which company that is.
Read the figures with care: a company in a group can look strong because of group contributions, or weak because dividends go up to the parent. The figures are indications, not the full picture.
We do not show the group structure, because open data does not say who owns whom.
Public contracts
- Contracts awarded since 2024
- 1
- Total awarded value since 2024
- value not stated
- 1 contracts without a stated value are not in the total.
| Date | Buyer | Notice | Value |
|---|---|---|---|
| 13 February 2025 | Oslo kommune v/ Sykehjemsetaten | Anskaffelse av tjenesteytingsavtaler til Kantarellenhjemmet og Uranienborghjemmet | value not stated |
Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.
Source: Doffin (DFØ), fetched 27 October 2026. Winners are matched on organisation number.
Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0
From the Central Coordinating Register
- Org. no.
- 925589837
- Legal form
- AS · part of a group
- Sector
- Helse og omsorg (87.102)
- Morning company class
- Medium
- Employees
- 495 registered 10 October 2026
- Founded
- 1 August 2020 6 years in operation
- Share capital
- 5.71 MNOK
- Business address
- Oscars gate 30, 0352 OSLO
- Municipality
- Oslo rank 63–220 of 357 in Norway
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 31 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 31 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 3 | 33 | 35 | |
| Rank | 1,889 | 1,578 | 1,574 | |
| Operating margin | −6.7% | −0.9% | −2.3% | |
| Return on assets | −92.7% | 0.4% | −7.7% | |
| Equity ratio | −184.7% | 78.9% | 27.7% | |
| Current ratio | 0.20 | 0.37 | 0.76 | |
| Revenue growth | – | −61.6% | 1,987.3% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 25.9 MNOK | 10.0 MNOK | 207.8 MNOK |
| Operating profit | −1.7 MNOK | −0.1 MNOK | −4.8 MNOK |
| Profit before tax | −1.8 MNOK | −0.2 MNOK | −5.2 MNOK |
| Net profit | −1.8 MNOK | −0.2 MNOK | −5.2 MNOK |
| Financial expenses | 0.1 MNOK | 0.3 MNOK | 0.5 MNOK |
| Total assets | 1.9 MNOK | 33.4 MNOK | 61.8 MNOK |
| Current assets | 1.1 MNOK | 2.6 MNOK | 28.8 MNOK |
| Equity | −3.4 MNOK | 26.4 MNOK | 17.1 MNOK |
| Retained earnings | −3.5 MNOK | −3.7 MNOK | −8.9 MNOK |
| Total liabilities | 5.3 MNOK | 7.0 MNOK | 44.6 MNOK |
| Current liabilities | 5.3 MNOK | 7.0 MNOK | 38.0 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 31 October 2026, accounts id 7082532.
Further
Similar companies
- Revmatismesykehuset AS index 35, rank 1,564 · compare
- Varodd Inkludering AS index 35, rank 1,565 · compare
- Fornebuklinikken AS index 35, rank 1,573 · compare
- Grefsenhjemmet Sykehjemsdrift AS index 35, rank 1,575 · compare
- Ecura Bpa AS index 35, rank 1,579 · compare